Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

ICU Medical, Inc.

ICUINASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed Sep 1, 2026Accepted Sep 1, 2026, 5:21 PM EDTFiling CIK 883984Accession 0001804831-26-000006
Share

Structured filing — 4

edgardoc.xml

Open full document ↗

Filing details

Report period
2026-09-01
Issuer
ICU MEDICAL INC/DE
Issuer CIK
0000883984
Trading symbol
ICUI
Rule 10b5-1 indication
Checked

Reporting owner 1

Name
Bonnell Brian Michael
Reporting owner CIK
0001804831
Relationship
Officer
Officer title
Chief Financial Officer
Address
951 CALLE AMANECER, SAN CLEMENTE, CA, 92673

Non-derivative transactions

Non-derivative transactions · 1 reported row
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnership
Common Stock2026-09-01S · Form 46,381[F1]D175.0[F2]56,062D
Table key
S · Form 4
Sale on the market or privately
D
Direct

Footnotes

F1
The restricted award sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 1, 2026.↩ 1
F2
All shares sold were sold at the exact price disclosed.↩ 1

Signature 1

Signed
By: Paula Darbyshire, Attorney-in-Fact For: Brian Bonnell
Date
2026-09-01

Company context

Current securities

Recent company filings

  1. 10-Q filingNov 5, 2026
  2. Results of Operations and Financial ConditionNov 5, 2026
  3. 144 filingSep 3, 2026
  4. 144 filingSep 1, 2026
  5. 144 filingAug 31, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.